- Home
- ABUS vs PUBM Comparison
ABUS vs PUBM Comparison
Compare ABUS & PUBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- PUBM
- Stock Information
- Founded
- ABUS N/A
- PUBM 2006
- Country
- ABUS United States
- PUBM United States
- Employees
- ABUS N/A
- PUBM N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- PUBM Computer Software: Prepackaged Software
- Sector
- ABUS Health Care
- PUBM Technology
- Exchange
- ABUS Nasdaq
- PUBM Nasdaq
- Market Cap
- ABUS 725.9M
- PUBM 724.9M
- IPO Year
- ABUS N/A
- PUBM 2020
- Fundamental
- Price
- ABUS $3.51
- PUBM $16.18
- Analyst Decision
- ABUS Strong Buy
- PUBM Buy
- Analyst Count
- ABUS 4
- PUBM 7
- Target Price
- ABUS $5.50
- PUBM $20.67
- AVG Volume (30 Days)
- ABUS 864.7K
- PUBM 479.0K
- Earning Date
- ABUS 11-06-2024
- PUBM 11-12-2024
- Dividend Yield
- ABUS N/A
- PUBM N/A
- EPS Growth
- ABUS N/A
- PUBM 553.89
- EPS
- ABUS N/A
- PUBM 0.32
- Revenue
- ABUS $6,742,000.00
- PUBM $290,354,000.00
- Revenue This Year
- ABUS N/A
- PUBM $10.76
- Revenue Next Year
- ABUS N/A
- PUBM $9.74
- P/E Ratio
- ABUS N/A
- PUBM $50.40
- Revenue Growth
- ABUS N/A
- PUBM 13.11
- 52 Week Low
- ABUS $1.79
- PUBM $13.18
- 52 Week High
- ABUS $4.72
- PUBM $25.36
- Technical
- Relative Strength Index (RSI)
- ABUS 34.90
- PUBM 57.73
- Support Level
- ABUS $3.42
- PUBM $14.42
- Resistance Level
- ABUS $3.56
- PUBM $15.99
- Average True Range (ATR)
- ABUS 0.16
- PUBM 0.80
- MACD
- ABUS -0.03
- PUBM 0.04
- Stochastic Oscillator
- ABUS 16.67
- PUBM 54.52
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
About PUBM PubMatic Inc.
PubMatic is one of the leading supply-side platform providers in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, better manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). PubMatic generates revenue mainly via taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Given the growth in overall digital advertising, more publishers and advertisers are adopting programmatic (or automated) buying and selling, driving the firm's success in attracting more inventory.